Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch

F. Albani, B. Grassi, R. Ferrara, R. Turrini, A. Baruzzi, U. Aguglia, C. Albano, L. Antonini, G. Avanzini, P. Basso, P. Benna, R. Canger, D. Consoli, P. D'Alessandro, O. Daniele, C. A. Defanti, G. Ferrari, P. Garofalo, A. T. Giallonardo, M. T. GiordanaG. Liguori, F. Marrosu, G. Masè, S. Mazza, F. Minicucci, L. Murri, G. Muscas, S. Musumeci, A. Paggi, B. Passarella, F. Puca, V. Santamato, R. Sterzi, S. Striano, P. Tanganelli, C. A. Tassinari, T. Tassinari, R. Tata, G. Vatti, C. Zucca

Research output: Contribution to journalArticle

Abstract

This study compared immediate (overnight) and progressive switching to oxcarbazepine monotherapy in patients with partial seizures unsatisfactorily treated with carbamazepine monotherapy. Patients were randomised to either an overnight (n = 140) or a progressive switch (n = 146) from carbamazepine to oxcarbazepine monotherapy at a dose ratio of 1:1.5. The difference between the two switch groups in the mean monthly seizure frequency supported the equivalence of overnight and progressive switching (difference of 0.02 excluding outliers; 95% confidence interval (CI) -0.74, 0.78). Following the switch from carbamazepine to oxcarbazepine, there was a reduction in median monthly seizure frequency in both the overnight group (from 1.5 to 0; P = 0.0005) and the progressive group (from 1.0 to 0.4; P = 0.003). The proportion of seizure-free patients increased from 38 to 51% (P = 0.002) and 39 to 49% (P = -0.01) in the overnight and progressive groups, respectively. In addition, the proportion of patients experiencing no clinically significant adverse events did not differ between the two switch methods (difference of 2.5; 95% CI -4.1, 9.0). For patients who are unsatisfactorily treated with carbamazepine monotherapy, overnight switch to oxcarbazepine monotherapy is as effective and well tolerated as a progressive switch, therefore allowing simple and flexible individualised treatment. Switching to oxcarbazepine monotherapy appears to be beneficial for patients who are unsatisfactorily treated with carbamazepine monotherapy, independently of the switch method used.

Original languageEnglish
Pages (from-to)254-263
Number of pages10
JournalSeizure
Volume13
Issue number4
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Carbamazepine
Seizures
Confidence Intervals
oxcarbazepine

Keywords

  • Carbamazepine
  • Epilepsy
  • Immediate
  • Monotherapy
  • Oxcarbazepine
  • Switch

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Psychology(all)

Cite this

Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. / Albani, F.; Grassi, B.; Ferrara, R.; Turrini, R.; Baruzzi, A.; Aguglia, U.; Albano, C.; Antonini, L.; Avanzini, G.; Basso, P.; Benna, P.; Canger, R.; Consoli, D.; D'Alessandro, P.; Daniele, O.; Defanti, C. A.; Ferrari, G.; Garofalo, P.; Giallonardo, A. T.; Giordana, M. T.; Liguori, G.; Marrosu, F.; Masè, G.; Mazza, S.; Minicucci, F.; Murri, L.; Muscas, G.; Musumeci, S.; Paggi, A.; Passarella, B.; Puca, F.; Santamato, V.; Sterzi, R.; Striano, S.; Tanganelli, P.; Tassinari, C. A.; Tassinari, T.; Tata, R.; Vatti, G.; Zucca, C.

In: Seizure, Vol. 13, No. 4, 06.2004, p. 254-263.

Research output: Contribution to journalArticle

Albani, F, Grassi, B, Ferrara, R, Turrini, R, Baruzzi, A, Aguglia, U, Albano, C, Antonini, L, Avanzini, G, Basso, P, Benna, P, Canger, R, Consoli, D, D'Alessandro, P, Daniele, O, Defanti, CA, Ferrari, G, Garofalo, P, Giallonardo, AT, Giordana, MT, Liguori, G, Marrosu, F, Masè, G, Mazza, S, Minicucci, F, Murri, L, Muscas, G, Musumeci, S, Paggi, A, Passarella, B, Puca, F, Santamato, V, Sterzi, R, Striano, S, Tanganelli, P, Tassinari, CA, Tassinari, T, Tata, R, Vatti, G & Zucca, C 2004, 'Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch', Seizure, vol. 13, no. 4, pp. 254-263. https://doi.org/10.1016/j.seizure.2003.08.006
Albani, F. ; Grassi, B. ; Ferrara, R. ; Turrini, R. ; Baruzzi, A. ; Aguglia, U. ; Albano, C. ; Antonini, L. ; Avanzini, G. ; Basso, P. ; Benna, P. ; Canger, R. ; Consoli, D. ; D'Alessandro, P. ; Daniele, O. ; Defanti, C. A. ; Ferrari, G. ; Garofalo, P. ; Giallonardo, A. T. ; Giordana, M. T. ; Liguori, G. ; Marrosu, F. ; Masè, G. ; Mazza, S. ; Minicucci, F. ; Murri, L. ; Muscas, G. ; Musumeci, S. ; Paggi, A. ; Passarella, B. ; Puca, F. ; Santamato, V. ; Sterzi, R. ; Striano, S. ; Tanganelli, P. ; Tassinari, C. A. ; Tassinari, T. ; Tata, R. ; Vatti, G. ; Zucca, C. / Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. In: Seizure. 2004 ; Vol. 13, No. 4. pp. 254-263.
@article{18b92eec800d450e8ba2bb65ea9444a9,
title = "Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch",
abstract = "This study compared immediate (overnight) and progressive switching to oxcarbazepine monotherapy in patients with partial seizures unsatisfactorily treated with carbamazepine monotherapy. Patients were randomised to either an overnight (n = 140) or a progressive switch (n = 146) from carbamazepine to oxcarbazepine monotherapy at a dose ratio of 1:1.5. The difference between the two switch groups in the mean monthly seizure frequency supported the equivalence of overnight and progressive switching (difference of 0.02 excluding outliers; 95{\%} confidence interval (CI) -0.74, 0.78). Following the switch from carbamazepine to oxcarbazepine, there was a reduction in median monthly seizure frequency in both the overnight group (from 1.5 to 0; P = 0.0005) and the progressive group (from 1.0 to 0.4; P = 0.003). The proportion of seizure-free patients increased from 38 to 51{\%} (P = 0.002) and 39 to 49{\%} (P = -0.01) in the overnight and progressive groups, respectively. In addition, the proportion of patients experiencing no clinically significant adverse events did not differ between the two switch methods (difference of 2.5; 95{\%} CI -4.1, 9.0). For patients who are unsatisfactorily treated with carbamazepine monotherapy, overnight switch to oxcarbazepine monotherapy is as effective and well tolerated as a progressive switch, therefore allowing simple and flexible individualised treatment. Switching to oxcarbazepine monotherapy appears to be beneficial for patients who are unsatisfactorily treated with carbamazepine monotherapy, independently of the switch method used.",
keywords = "Carbamazepine, Epilepsy, Immediate, Monotherapy, Oxcarbazepine, Switch",
author = "F. Albani and B. Grassi and R. Ferrara and R. Turrini and A. Baruzzi and U. Aguglia and C. Albano and L. Antonini and G. Avanzini and P. Basso and P. Benna and R. Canger and D. Consoli and P. D'Alessandro and O. Daniele and Defanti, {C. A.} and G. Ferrari and P. Garofalo and Giallonardo, {A. T.} and Giordana, {M. T.} and G. Liguori and F. Marrosu and G. Mas{\`e} and S. Mazza and F. Minicucci and L. Murri and G. Muscas and S. Musumeci and A. Paggi and B. Passarella and F. Puca and V. Santamato and R. Sterzi and S. Striano and P. Tanganelli and Tassinari, {C. A.} and T. Tassinari and R. Tata and G. Vatti and C. Zucca",
year = "2004",
month = "6",
doi = "10.1016/j.seizure.2003.08.006",
language = "English",
volume = "13",
pages = "254--263",
journal = "Seizure : the journal of the British Epilepsy Association",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch

AU - Albani, F.

AU - Grassi, B.

AU - Ferrara, R.

AU - Turrini, R.

AU - Baruzzi, A.

AU - Aguglia, U.

AU - Albano, C.

AU - Antonini, L.

AU - Avanzini, G.

AU - Basso, P.

AU - Benna, P.

AU - Canger, R.

AU - Consoli, D.

AU - D'Alessandro, P.

AU - Daniele, O.

AU - Defanti, C. A.

AU - Ferrari, G.

AU - Garofalo, P.

AU - Giallonardo, A. T.

AU - Giordana, M. T.

AU - Liguori, G.

AU - Marrosu, F.

AU - Masè, G.

AU - Mazza, S.

AU - Minicucci, F.

AU - Murri, L.

AU - Muscas, G.

AU - Musumeci, S.

AU - Paggi, A.

AU - Passarella, B.

AU - Puca, F.

AU - Santamato, V.

AU - Sterzi, R.

AU - Striano, S.

AU - Tanganelli, P.

AU - Tassinari, C. A.

AU - Tassinari, T.

AU - Tata, R.

AU - Vatti, G.

AU - Zucca, C.

PY - 2004/6

Y1 - 2004/6

N2 - This study compared immediate (overnight) and progressive switching to oxcarbazepine monotherapy in patients with partial seizures unsatisfactorily treated with carbamazepine monotherapy. Patients were randomised to either an overnight (n = 140) or a progressive switch (n = 146) from carbamazepine to oxcarbazepine monotherapy at a dose ratio of 1:1.5. The difference between the two switch groups in the mean monthly seizure frequency supported the equivalence of overnight and progressive switching (difference of 0.02 excluding outliers; 95% confidence interval (CI) -0.74, 0.78). Following the switch from carbamazepine to oxcarbazepine, there was a reduction in median monthly seizure frequency in both the overnight group (from 1.5 to 0; P = 0.0005) and the progressive group (from 1.0 to 0.4; P = 0.003). The proportion of seizure-free patients increased from 38 to 51% (P = 0.002) and 39 to 49% (P = -0.01) in the overnight and progressive groups, respectively. In addition, the proportion of patients experiencing no clinically significant adverse events did not differ between the two switch methods (difference of 2.5; 95% CI -4.1, 9.0). For patients who are unsatisfactorily treated with carbamazepine monotherapy, overnight switch to oxcarbazepine monotherapy is as effective and well tolerated as a progressive switch, therefore allowing simple and flexible individualised treatment. Switching to oxcarbazepine monotherapy appears to be beneficial for patients who are unsatisfactorily treated with carbamazepine monotherapy, independently of the switch method used.

AB - This study compared immediate (overnight) and progressive switching to oxcarbazepine monotherapy in patients with partial seizures unsatisfactorily treated with carbamazepine monotherapy. Patients were randomised to either an overnight (n = 140) or a progressive switch (n = 146) from carbamazepine to oxcarbazepine monotherapy at a dose ratio of 1:1.5. The difference between the two switch groups in the mean monthly seizure frequency supported the equivalence of overnight and progressive switching (difference of 0.02 excluding outliers; 95% confidence interval (CI) -0.74, 0.78). Following the switch from carbamazepine to oxcarbazepine, there was a reduction in median monthly seizure frequency in both the overnight group (from 1.5 to 0; P = 0.0005) and the progressive group (from 1.0 to 0.4; P = 0.003). The proportion of seizure-free patients increased from 38 to 51% (P = 0.002) and 39 to 49% (P = -0.01) in the overnight and progressive groups, respectively. In addition, the proportion of patients experiencing no clinically significant adverse events did not differ between the two switch methods (difference of 2.5; 95% CI -4.1, 9.0). For patients who are unsatisfactorily treated with carbamazepine monotherapy, overnight switch to oxcarbazepine monotherapy is as effective and well tolerated as a progressive switch, therefore allowing simple and flexible individualised treatment. Switching to oxcarbazepine monotherapy appears to be beneficial for patients who are unsatisfactorily treated with carbamazepine monotherapy, independently of the switch method used.

KW - Carbamazepine

KW - Epilepsy

KW - Immediate

KW - Monotherapy

KW - Oxcarbazepine

KW - Switch

UR - http://www.scopus.com/inward/record.url?scp=2342494386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342494386&partnerID=8YFLogxK

U2 - 10.1016/j.seizure.2003.08.006

DO - 10.1016/j.seizure.2003.08.006

M3 - Article

C2 - 15121136

AN - SCOPUS:2342494386

VL - 13

SP - 254

EP - 263

JO - Seizure : the journal of the British Epilepsy Association

JF - Seizure : the journal of the British Epilepsy Association

SN - 1059-1311

IS - 4

ER -